BlackRock’s Cantel Medical Corporation CMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-4,861,453
| Closed | -$388M | – | 5626 |
|
|
2021
Q1 | $388M | Buy |
4,861,453
+21,886
| +0.5% | +$1.71M | 0.01% | 1236 |
|
|
2020
Q4 | $382M | Buy |
4,839,567
+332,231
| +7% | +$19.5M | 0.01% | 1095 |
|
|
2020
Q3 | $198M | Sell |
4,507,336
-102,891
| -2% | -$5.07M | 0.01% | 1396 |
|
|
2020
Q2 | $204M | Buy |
4,610,227
+1,147,063
| +33% | +$42.8M | 0.01% | 1352 |
|
|
2020
Q1 | $124M | Sell |
3,463,164
-52,338
| -1% | -$2.98M | 0.01% | 1498 |
|
|
2019
Q4 | $249M | Buy |
3,515,502
+92,264
| +3% | +$6.69M | 0.01% | 1315 |
|
|
2019
Q3 | $256M | Sell |
3,423,238
-54,331
| -2% | -$4.61M | 0.01% | 1224 |
|
|
2019
Q2 | $280M | Buy |
3,477,569
+50,862
| +1% | +$3.58M | 0.01% | 1177 |
|
|
2019
Q1 | $229M | Sell |
3,426,707
-185,203
| -5% | -$14M | 0.01% | 1314 |
|
|
2018
Q4 | $269M | Sell |
3,611,910
-42,520
| -1% | -$3.51M | 0.01% | 1085 |
|
|
2018
Q3 | $336M | Buy |
3,654,430
+155,603
| +4% | +$14.8M | 0.01% | 1071 |
|
|
2018
Q2 | $344M | Sell |
3,498,827
-693,427
| -17% | -$77.6M | 0.02% | 1014 |
|
|
2018
Q1 | $467M | Sell |
4,192,254
-561,440
| -12% | -$62.9M | 0.02% | 744 |
|
|
2017
Q4 | $489M | Sell |
4,753,694
-55,725
| -1% | -$5.55M | 0.02% | 713 |
|
|
2017
Q3 | $453M | Sell |
4,809,419
-20,148
| -0.4% | -$1.59M | 0.02% | 728 |
|
|
2017
Q2 | $376M | Sell |
4,829,567
-328,356
| -6% | -$24.7M | 0.02% | 813 |
|
|
2017
Q1 | $413M | Buy |
5,157,923
+5,141,482
| +31,272% | +$409M | 0.02% | 757 |
|
|
2016
Q4 | $1.29M | Buy |
16,441
+7,127
| +77% | +$554K | ﹤0.01% | 1403 |
|
|
2016
Q3 | $726K | Buy |
9,314
+3,055
| +49% | +$222K | ﹤0.01% | 1614 |
|
|
2016
Q2 | $429K | Buy |
6,259
+3,904
| +166% | +$269K | ﹤0.01% | 1732 |
|
|
2016
Q1 | $168K | Buy |
2,355
+1,282
| +119% | +$80.5K | ﹤0.01% | 1780 |
|
|
2015
Q4 | $67K | Buy |
1,073
+238
| +29% | +$14.5K | ﹤0.01% | 1912 |
|
|
2015
Q3 | $48K | Sell |
835
-118
| -12% | -$6.25K | ﹤0.01% | 1929 |
|
|
2015
Q2 | $51K | Sell |
953
-57
| -6% | -$2.77K | ﹤0.01% | 1974 |
|
|
2015
Q1 | $48K | Hold |
1,010
| – | – | ﹤0.01% | 1972 |
|
|
2014
Q4 | $44K | Hold |
1,010
| – | – | ﹤0.01% | 1997 |
|
|
2014
Q3 | $35K | Hold |
1,010
| – | – | ﹤0.01% | 2081 |
|
|
2014
Q2 | $37K | Buy |
1,010
+181
| +22% | +$6.14K | ﹤0.01% | 2075 |
|
|
2014
Q1 | $28K | Hold |
829
| – | – | ﹤0.01% | 2193 |
|
|
2013
Q4 | $28K | Hold |
829
| – | – | ﹤0.01% | 2196 |
|
|
2013
Q3 | $26K | Sell |
829
-901
| -52% | -$24K | ﹤0.01% | 2136 |
|
|
2013
Q2 | $39K | Buy |
+1,730
| New | +$37.5K | ﹤0.01% | 1967 |
|
BlackRock's CMD Position: Q2 2021 in Review
BlackRock sold out of Cantel Medical Corporation (CMD) in Q2 2021, closing a stake of 4,861,453 shares — an estimated $388M sold.
BlackRock first reported a position in CMD in Q2 2013 and held it in 32 quarters. The position peaked at $489M in Q4 2017. 0 funds tracked by Wall St. Rank hold CMD as of Q2 2021.
- BlackRock reported no remaining Cantel Medical Corporation position as of Q2 2021 after selling out during the quarter.
- BlackRock sold 4,861,453 Cantel Medical Corporation shares in Q2 2021, an estimated $388M.
- BlackRock first reported a position in Cantel Medical Corporation in Q2 2013 and held it in 32 quarters.
- BlackRock's Cantel Medical Corporation position peaked at $489M in Q4 2017.
- 0 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q2 2021.
Based on BlackRock's 13F filing for Q2 2021, filed 11 Aug 2021.